711 results on '"Hong, W. K."'
Search Results
2. Retinoid chemoprevention of aerodigestive carcinogenesis
3. Proteolytic stability of recombinant human serum albumin secreted in the yeast Saccharomyces cerevisiae
4. The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival
5. Chimney-Shaped and Plateau-Shaped Gate Electrode Field Emission Arrays
6. A case of supraumbilical skin rash after chemoembolization for hepatocellular carcinoma
7. Herpes zoster complicated by delayed intracranial haemorrhage
8. Hobnail haemangioma associated with a secondary sexual characteristic
9. High production of D-β-hydroxyisobutyric acid from methacrylic acid by Candida rugosa and its mutant
10. A case of adult blaschkitis with features of interface dermatitis
11. Pseudoxanthoma elasticum-like papillary dermal elastolysis with solar elastosis
12. Intramuscular lipoma of the sternocleidomastoid muscle
13. Phase II study of tallysomycin S10b in patients with advanced head and neck cancer
14. Folk yoghurt kills Helicobacter pylori
15. Adenovirus-Mediated p53 Gene Transfer in Sequence With Cisplatin to Tumors of Patients With Non–Small-Cell Lung Cancer
16. Chimney-Shaped and Plateau-Shaped Gate Electrode Field Emission Arrays
17. The Effect of Diethyldithiocarbamate (DDTC) on Response, Toxicity and Pharmacology of Cisplatin in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck
18. Chemotherapy of Head and Neck Cancer
19. The influence of cytoreductive surgery on the response to chemotherapy of a rat renal cancer
20. Flatness control using a contact type of shapemeter for continuous hot strip rolling
21. Aging-Dependent Electrical Properties in Polymer-Passivated ZnO Nanowire Field Effect Transistors
22. Fabrication of Ag Nanorods-Embedded P3HT/PCBM Films for the Enhancement of Light Absorption
23. Optical Characterization of Ge-on-Si Grown by using RTCVD
24. Lectures
25. Do elderly chemorefractory NSCLC patients derive benefit from salvage targeted therapy? Subgroup analysis of clinical outcome and toxicity from the BATTLE trial.
26. Biologic risk model for recurrence in resected early-stage non-small cell lung cancer (ES NSCLC).
27. DNA methyltransferase-3B (DNMT3B) in oral cancer (OC) development.
28. Phase II trial of erlotinib and radiotherapy following chemoradiotherapy for patients with stage III non-small cell lung cancer.
29. Biologic risk model development for recurrent and second primary tumors (SPTs) in patients (pts) with early stage non-small cell lung cancer (ES NSCLC).
30. Evaluation of Src Tyr419 as a predictive biomarker in a neoadjuvant trial using dasatinib in resectable malignant pleural mesothelioma.
31. Gene expression profiling of oral preneoplastic lesions (OPL) from a prospective prevention trial.
32. Human papillomavirus (HPV) transmission from oropharyngeal cancer patients to sexual partners.
33. Sorafenib treatment efficacy and KRAS biomarker status in the Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial.
34. Comprehensive analysis of expression patterns of insulin-like growth factor and Src pathway in patients with non-small cell lung cancer: Two large, independent series of tissue microarray.
35. OR8,48 Differential impacts of IGFBP-3 in epithelial IGF-induced lung cancer development
36. Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in situ hybridization. Mapping genotype/phenotype heterogeneity
37. Association between human papillomavirus (HPV) status with serum cytokine and angiogenic factor (CAF) profile after induction chemotherapy in head and neck squamous cell carcinoma (HNSCC)
38. Phase I trial of neoadjuvant dasatinib in patients with resectable malignant pleural mesothelioma
39. Phase II pilot study of neoadjuvant docetaxel and cisplatin followed by adjuvant erlotinib in patients with stage I-III non-small cell lung cancer (NSCLC)
40. Phase II randomized study of biomarker-directed treatment for non-small cell lung cancer (NSCLC): The BATTLE (Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination) clinical trial program
41. Cyclin D1 and Cancer Development in Laryngeal Premalignancy Patients
42. Correlation between plasma cytokine/angiogenic factors (C/AF) and signaling pathways activation from baseline tumor biopsy specimens in patients with advanced non small cell lung cancer (NSCLC): Preliminary analysis from the Biomarker-based Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) Clinical Study
43. A randomized double-blind study of the biological effects of celecoxib as a chemopreventive agent in current and former smokers
44. Proliferative Changes in the Bronchial Epithelium of Former Smokers Treated With Retinoids
45. A clinical trial design applying Bayesian adaptive randomization for targeted therapy development in lung cancer: A step toward personalized medicine
46. New perspectives on metastatic patterns in lung cancer: The M. D. Anderson thoracic medical oncology database
47. Intramuscular lipoma of the sternocleidomastoid muscle
48. Structural Basis for Depletion of Heat Shock Protein 90 Client Proteins by Deguelin
49. A Risk Model for Prediction of Lung Cancer
50. Insulin-like growth factor-1 receptor/epidermal growth factor receptor (EGFR) heterodimerization and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.